Search

everythinglearnresearchcommunity

for

Search:↓

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Organoid technology helps create mini-organs for studying diseases and testing drugs.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Five FDA-approved drugs may help block COVID-19 virus entry.

Pomegranate has health benefits and new methods are improving its use in supplements.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 infection can significantly cause temporary hair loss.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

iPSCs are promising for studying and treating COVID-19.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

COVID-19 may trigger sudden temporary hair loss.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

% free PSA and urinary markers help better identify prostate cancer.

Cannabis has anti-inflammatory and antimicrobial properties, but more research is needed on its effects on plant and aquatic animal pathogens.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

We need safe, affordable drugs to fight coronaviruses effectively.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.